肺纤维化R量表:评估健康相关生活质量的简易视觉工具
本研究开发了针对特发性肺纤维化(IPF)患者的五条目数字评定量表R-Scale-PF,并在100例连续IPF患者中与K-BILD、EQ-5D-5L及生理指标进行比较。结果显示R-Scale-PF内部一致性高(Cronbach's α 0.825),与K-BILD(r=-0.713)和EQ-5D-5L(r=-0.665)的同时效度中至高,与生理指标同时效度中等。作者希望该简易工具经其他中心验证后可用于常规临床实践客观评估HRQoL。
要点
- R-Scale-PF为五条目数字评定量表,可在常规门诊快速评估IPF患者HRQoL。
- 与K-BILD(r=-0.713)和EQ-5D-5L(r=-0.665)同时效度中至高,内部一致性高。
- 与FVC(r=-0.307)和6分钟步行距离(r=-0.383)同时效度中等,已知组效度良好。
核心结论
- R-Scale-PF与K-BILD和EQ-5D-5L相关性良好,有望在常规临床实践中客观测量IPF患者HRQoL,但需在其他中心患者中验证。
研究设计与样本
- 开发性研究,纳入100例连续在间质性肺病中心管理的IPF患者,完成R-Scale-PF、K-BILD和EQ-5D-5L,并接受肺功能与6分钟步行试验。
- 其中53例在随访时再次完成三种HRQoL工具。
主要发现
- 全部100例患者成功完成三种HRQoL工具。
- 内部一致性高(Cronbach's α 0.825),地板/天花板效应极小。
- 与K-BILD同时效度中至高(r=-0.713),与EQ-5D-5L同时效度中至高(r=-0.665)。
- 与生理指标同时效度中等:用力肺活量(r=-0.307),6分钟步行距离(r=-0.383)。
- 跨疾病严重程度分期比较时已知组效度良好。
临床怎么用
- R-Scale-PF为五条目简易数字评定量表,可在IPF患者常规门诊就诊时快速评估HRQoL。
- 该工具与已验证的K-BILD和EQ-5D-5L相关性良好,可作为常规临床实践中客观测量HRQoL的候选工具。
- 在推广至其他中心前,需在外部患者人群中进一步验证。
局限性
- 作者指出该工具仍需在其他中心的患者中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Patients with idiopathic pulmonary fibrosis (IPF) experience impaired health-related quality of life (HRQoL). Several tools have been developed to objectively assess HRQoL in this patient population, but none are in use in routine clinical practice. OBJECTIVES: To develop a rapid, specific tool that can be used for patients with IPF during routine clinic visits. METHODS: A novel and simple five-item numerical rating scale was developed and compared with two other previously validated tools. 100 consecutive patients with IPF managed at a centre for interstitial lung disease were recruited to complete the Raghu scale for pulmonary fibrosis (R-Scale-PF), King's Brief Interstitial Lung Disease questionnaire (K-BILD), and the EuroQol Five-Dimensional Five-Level questionnaire (EQ-5D-5L) in addition to pulmonary function and 6-min walk tests. MEASUREMENTS AND MAIN RESULTS: All 100 patients successfully completed the three HRQoL tools with 53 completing them again at follow-up visits. Internal consistency was high (Cronbach's α 0.825) with minimal floor/ceiling effect. Concurrent validity of the R-Scale-PF was moderate to high compared with the K-BILD (r=-0.713) and the EQ-5D-5L (r=-0.665). Concurrent validity was moderate with physiologic measures (forced vital capacity, r=-0.307, 6-min walking distance, r=-0.383). The R-Scale-PF demonstrated good known-groups validity when comparing scores across stages of disease severity. CONCLUSIONS: The R-Scale-PF correlates well with the K-BILD and EQ-5D-5L. It is hoped that this novel simple numerical rating scale tool, subject to validation in patients from other centres, will provide an opportunity to objectively measure HRQoL in routine clinical practice for patients with IPF.
引用
- Scallan C, Strand L, Hayes J, et al. R-scale for pulmonary fibrosis: a simple, visual tool for the assessment of health-related quality of life. Eur Respir J. 2022. PMID: 34112729. doi:10.1183/13993003.00917-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。